PD-Spine-New Product
Device Product Development
General payments
$351,012
Research payments
$900
Through program year 2024, $351,012 in general payments and $900 in research payments were reported against PD-Spine-New Product (Product Development).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $38,623 | 46 |
| 2023 | General | $111,703 | 161 |
| 2022 | General | $27,659 | 36 |
| 2021 | General | $21,356 | 16 |
| 2020 | General | $151,671 | 169 |
| 2020 | Research | $900 | 3 |
Breakdown
The top 5 of 6 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
428 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.